Cargando…
The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665301/ http://dx.doi.org/10.1182/blood-2022-170154 |
| _version_ | 1784831262099243008 |
|---|---|
| author | Ujjani, Chaitra S. Poh, Christina Tu, Brian Lee, Sydney Selke, Stacy Zhu, Haiying Shadman, Mazyar Lynch, Ryan C. Huang, Meei-Li W Gopal, Ajay K. Warren, Edus H. Till, Brian G. Smith, Stephen D Sperling, Amy Hill, Joshua A. Stevenson, Philip Nielsen, Leslie Gooley, Ted A. Greninger, Alexander L |
| author_facet | Ujjani, Chaitra S. Poh, Christina Tu, Brian Lee, Sydney Selke, Stacy Zhu, Haiying Shadman, Mazyar Lynch, Ryan C. Huang, Meei-Li W Gopal, Ajay K. Warren, Edus H. Till, Brian G. Smith, Stephen D Sperling, Amy Hill, Joshua A. Stevenson, Philip Nielsen, Leslie Gooley, Ted A. Greninger, Alexander L |
| author_sort | Ujjani, Chaitra S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665301 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96653012022-11-16 The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up Ujjani, Chaitra S. Poh, Christina Tu, Brian Lee, Sydney Selke, Stacy Zhu, Haiying Shadman, Mazyar Lynch, Ryan C. Huang, Meei-Li W Gopal, Ajay K. Warren, Edus H. Till, Brian G. Smith, Stephen D Sperling, Amy Hill, Joshua A. Stevenson, Philip Nielsen, Leslie Gooley, Ted A. Greninger, Alexander L Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665301/ http://dx.doi.org/10.1182/blood-2022-170154 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Online Publication Only Ujjani, Chaitra S. Poh, Christina Tu, Brian Lee, Sydney Selke, Stacy Zhu, Haiying Shadman, Mazyar Lynch, Ryan C. Huang, Meei-Li W Gopal, Ajay K. Warren, Edus H. Till, Brian G. Smith, Stephen D Sperling, Amy Hill, Joshua A. Stevenson, Philip Nielsen, Leslie Gooley, Ted A. Greninger, Alexander L The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up |
| title | The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up |
| title_full | The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up |
| title_fullStr | The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up |
| title_full_unstemmed | The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up |
| title_short | The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up |
| title_sort | impact of b-cell-directed therapy on sars-cov-2 vaccine efficacy in cll: 1-year follow up |
| topic | Online Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665301/ http://dx.doi.org/10.1182/blood-2022-170154 |
| work_keys_str_mv | AT ujjanichaitras theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT pohchristina theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT tubrian theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT leesydney theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT selkestacy theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT zhuhaiying theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT shadmanmazyar theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT lynchryanc theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT huangmeeiliw theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT gopalajayk theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT warrenedush theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT tillbriang theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT smithstephend theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT sperlingamy theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT hilljoshuaa theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT stevensonphilip theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT nielsenleslie theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT gooleyteda theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT greningeralexanderl theimpactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT ujjanichaitras impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT pohchristina impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT tubrian impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT leesydney impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT selkestacy impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT zhuhaiying impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT shadmanmazyar impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT lynchryanc impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT huangmeeiliw impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT gopalajayk impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT warrenedush impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT tillbriang impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT smithstephend impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT sperlingamy impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT hilljoshuaa impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT stevensonphilip impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT nielsenleslie impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT gooleyteda impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup AT greningeralexanderl impactofbcelldirectedtherapyonsarscov2vaccineefficacyincll1yearfollowup |